Skip to main content


Page 9 of 36

  1. Organic cation transporter 1 primarily governs the action of metformin in the liver. There are considerable inter-individual variations in metformin response. In light of this, it is crucial to obtain a greate...

    Authors: Fizalah Kawoosa, Zafar A. Shah, Shariq R. Masoodi, Asif Amin, Roohi Rasool, Khalid M. Fazili, Abid Hamid Dar, Asif Lone and Samir ul Bashir
    Citation: BMC Endocrine Disorders 2022 22:140
  2. In this research, data of the DehPCS study were used to assess the validity of self-reported diabetes based on the reference criteria, including the history of taking oral anti-diabetic drugs, insulin injectio...

    Authors: Farhad Moradpour, Negar Piri, Hojat Dehghanbanadaki, Ghobad Moradi, Mahdiyeh Fotouk-Kiai and Yousef Moradi
    Citation: BMC Endocrine Disorders 2022 22:139
  3. Individually designed interventions delivered through mobile health applications (mHealth apps) may be able to effectively support diabetes self-care. Our aim was to review and synthesize available evidence in...

    Authors: Divya Anna Stephen, Anna Nordin, Jan Nilsson and Mona Persenius
    Citation: BMC Endocrine Disorders 2022 22:138
  4. Microvascular complications lead to disability, dependency, and accelerated morbidity and mortality. This study aimed to identify predictors of blood glucose change and time to microvascular complications amon...

    Authors: Nigusie Gashaye Shita and Ashagrie Sharew Iyasu
    Citation: BMC Endocrine Disorders 2022 22:136
  5. Existing reviews indicated that disease management for patients with diabetes may be effective in achieving better health outcomes with less resource utilization in the short term. However, the long-term resul...

    Authors: Hirohito Watanabe, Hisataka Anezaki, Kana Kazawa, Yuya Tamaki, Hideki Hashimoto and Michiko Moriyama
    Citation: BMC Endocrine Disorders 2022 22:135
  6. Appropriate service delivery, access to high quality of cares and optimal management of type 2 diabetes mellitus (T2DM) can decrease the risk of micro and macro vascular complications and mortality. Therefore,...

    Authors: Majid Davari, Yahya Bayazidi, Abbas Kebriaeezadeh, Alireza Esteghamati, Fatemeh Bandarian, Zahra Kashi, Adele Bahar and Sepideh Yousefi
    Citation: BMC Endocrine Disorders 2022 22:133
  7. There is almost no published data on the assessment of self-management practice among adult type II diabetes patients in Ethiopia. Hence, we aim to assess the level of self-management practice for people with ...

    Authors: Sileshi Tadesse Gemeda and Zinash Beyene Woldemariam
    Citation: BMC Endocrine Disorders 2022 22:132
  8. Obesity is a risk factor for metabolic diseases and often influences hormone change. Lipoprotein (a) (Lp(a)) is associated with various metabolic diseases, but there are few studies on the relationship between...

    Authors: Xiaona Chang, Nannan Bian, Xiaoyu Ding, Jinman Li, Yu An, Jiaxuan Wang, Jia Liu and Guang Wang
    Citation: BMC Endocrine Disorders 2022 22:131
  9. Adrenocortical carcinoma (ACC) is a highly malignant urologic cancer and tends to metastasize. Although immune checkpoint inhibitors (ICIs) bring a glimmer of light to conquer ACC, only a fraction of patients ...

    Authors: Fangshi Xu, Yibing Guan, Peng Zhang, Li Xue, Yubo Ma, Mei Gao, Tie Chong and Bin-Cheng Ren
    Citation: BMC Endocrine Disorders 2022 22:130
  10. Type 2 diabetes mellitus (T2DM) and non-alcoholic fatty liver disease frequently coexist and share pathophysiological manifestations. This study aimed to explore the association between T2DM status and prevale...

    Authors: Jun Chen, Piao Hu, Yanfei Wang and Zhongxin Zhu
    Citation: BMC Endocrine Disorders 2022 22:128
  11. We sought the association between serum 25-hydroxyvitamin D3 (25(OH) D3) levels and atherogenic indices of plasma as novel predictive biomarkers of cardiometabolic disease risk in patients with type 2 diabetes me...

    Authors: Mohammad Reza Mahmoodi and Hamid Najafipour
    Citation: BMC Endocrine Disorders 2022 22:126
  12. The cardiovascular effects of glucagon-like peptide-1 (GLP-1) receptor agonists are still controversial in the treatment of type 2 diabetes mellitus (T2DM) patients. The purpose of this study was to evaluate t...

    Authors: Jing Qin and Li Song
    Citation: BMC Endocrine Disorders 2022 22:125
  13. Diabetes mellitus is emerging as a major worldwide health problem that has a social, financial, and developmental impact on developing countries. Foot complications are among the most serious and costly compli...

    Authors: Enyew Getaneh Mekonen and Tizita Gebeyehu Demssie
    Citation: BMC Endocrine Disorders 2022 22:124
  14. The prevalence of diabetes mellitus (DM), cardio-cerebrovascular diseases (CCVDs) has increased during recent decades. We aimed to investigate the relationship between body mass index (BMI) and each of several...

    Authors: Yoon-Jong Bae, Sang-Jun Shin and Hee-Taik Kang
    Citation: BMC Endocrine Disorders 2022 22:123
  15. Anxiety, depression, and disease-related distress are linked to worse overall glycaemic control, in terms of HbA1c. This study was aimed to evaluate whether traits of these emotional disorders are associated w...

    Authors: Alejandro Déniz-García, Alba Díaz-Artiles, Pedro Saavedra, Dácil Alvarado-Martel, Ana M. Wägner and Mauro Boronat
    Citation: BMC Endocrine Disorders 2022 22:122
  16. Recent studies have shown that dietary carbohydrate quantity and quality as well as genetic variants may contribute to determining the metabolic rate and general and central obesity. This study aimed to examin...

    Authors: Shahab Alizadeh, Sara Pooyan, Atieh Mirzababaei, Hana Arghavani, Hossein Hasani and Khadijeh Mirzaei
    Citation: BMC Endocrine Disorders 2022 22:121
  17. The previous evidence shows that there is an association between total dietary polyphenols intake (DPI) and its subclasses and lower risk of metabolic Syndrome (MetS). This cross-sectional study aims to evalua...

    Authors: Yasaman Aali, Sara Ebrahimi, Farideh Shiraseb and Khadijeh Mirzaei
    Citation: BMC Endocrine Disorders 2022 22:120
  18. In this study, we investigated whether serum levels of advanced glycation end products (AGEs) independently correlated with relative muscle strength after adjustment for clinical variables including diabetic p...

    Authors: Tsung-Hui Wu, Shiow-Chwen Tsai, Hsuan-Wei Lin, Chiao-Nan Chen and Chii-Min Hwu
    Citation: BMC Endocrine Disorders 2022 22:118
  19. Inconsistencies in the management of hypothyroidism have been reported among endocrinologists in different European countries. Aim of this study was to explore Czech endocrinologists’ use of thyroid hormones i...

    Authors: Jan Jiskra, Jan Paleček, Roberto Attanasio, Laszlo Hegedüs, Endre V. Nagy, Enrico Papini, Petros Perros, Roberto Negro and Michal Kršek
    Citation: BMC Endocrine Disorders 2022 22:117
  20. Compliance to dietary recommendations by patients is the most difficult part of diabetes management. The nature of any educational method is to increase patients’ awareness. But the question is, what is the ef...

    Authors: Shahram Molavynejad, Mojtaba Miladinia and Mina Jahangiri
    Citation: BMC Endocrine Disorders 2022 22:116
  21. Obesity and body composition may be affected by the pro-inflammatory and anti-inflammatory components of diets. The aim of this study was to investigate associations between the dietary inflammatory index (DII...

    Authors: Maryam Gholamalizadeh, Mina Ahmadzadeh, Fatemeh BourBour, Farhad Vahid, Marjan Ajami, Nazanin Majidi, Azadeh Hajipour, Saeid Doaei, Naser Kalantari, Atiyeh Alizadeh and Alireza Mosavi Jarrahi
    Citation: BMC Endocrine Disorders 2022 22:115
  22. Studies have demonstrated the relationship between the fatty liver index (FLI) and metabolism, while few research reported its relationship with hyperuricemia (HUA). This study aimed to predict HUA by determin...

    Authors: Jianchang Qu, Jingtao Dou, Anping Wang, Yingshu Liu, Lu Lin, Kang Chen, Li Zang and Yiming Mu
    Citation: BMC Endocrine Disorders 2022 22:114
  23. The food and drug administration approved many drugs to treat diabetes mellitus, but those drugs do not have a noticeable effect on weight management. Recently, glucagon-like peptide 1 agonist known as Cotadut...

    Authors: Mahmoud M. Ali, Ahmed Hafez, Mahmoud Shaban Abdelgalil, Mohammed Tarek Hasan, Mohammed Magdy El-Ghannam, Osama M. Ghogar, Asmaa Ahmed Elrashedy and Mohamed Abd-ElGawad
    Citation: BMC Endocrine Disorders 2022 22:113
  24. Despite strong evidence of benefit, uptake of newer glucose-lowering medications that reduce cardiovascular risk has been low. We sought to examine global trends and predictors of use of SGLT2i and GLP-1 RA in...

    Authors: Suzanne V. Arnold, Fengming Tang, Andrew Cooper, Hungta Chen, Marilia B. Gomes, Wolfgang Rathmann, Iichiro Shimomura, Jiten Vora, Hirotaka Watada, Kamlesh Khunti and Mikhail Kosiborod
    Citation: BMC Endocrine Disorders 2022 22:111
  25. This study aimed to evaluate whether hypereosinophilia is a clinical biomarker of immune checkpoint inhibitor-induced hypopituitarism in patients with renal cell carcinoma treated with nivolumab plus ipilimumab.

    Authors: Hodaka Yamada, Satoshi Washino, Daisuke Suzuki, Rika Saikawa, Shiori Tonezawa, Rie Hagiwara, Shunsuke Funazaki, Masashi Yoshida, Tsuzumi Konishi, Kimitoshi Saito, Tomoaki Miyagawa and Kazuo Hara
    Citation: BMC Endocrine Disorders 2022 22:110
  26. Hyposalivation is one of the common symptoms of diabetes. Although long non-coding RNAs (lncRNAs) have recently been reported to play important roles in the pathogenesis of diabetes, the role of lncRNAs in dia...

    Authors: Xi-Jin Shi, Hui-Min Liu, Li Li, Yan Zhang, Xin Cong, Li-Mei Liu, Li-ling Wu and Ruo-Lan Xiang
    Citation: BMC Endocrine Disorders 2022 22:109
  27. ACTH-independent macronodular hyperplasia (AIMAH) is an uncommon disorder characterized by massive enlargement of both adrenal glands and hypersecretion of cortisol. Concomitant AIMAH and multiple endocrine ne...

    Authors: Vajihe Chavoshi, Seyed Saeed Tamehri Zadeh, Shayesteh Khalili, Amirhassan Rabbani, Seyed Amir Hassan Matini, Zhaleh Mohsenifar and Farzad Hadaegh
    Citation: BMC Endocrine Disorders 2022 22:108
  28. Thyroid cancer is the most prevalent endocrine malignancy. Long non-coding RNA (lncRNA) MIR31HG is abnormally expressed in thyroid cancer tissues. However, the precise, critical role of MIR31HG in thyroid canc...

    Authors: Shuwang Peng, Luyang Chen, Zhengtai Yuan and Shanshan Duan
    Citation: BMC Endocrine Disorders 2022 22:107
  29. The accumulation of advanced glycation end products (AGEs) occurring in skin tissues can be measured by AGE Reader. Here, we assessed the correlation between AGEs values and the development of type 2 diabetic ...

    Authors: Xing-Wang Zhao, Wan-Xu Yue, Sen-Wei Zhang and Qiu Chen
    Citation: BMC Endocrine Disorders 2022 22:106
  30. Neuroendocrine neoplasms are rare disease and could originate from throughout the body, however, there have been little epidemiological studies in Japan, especially the organ distribution. This study was to ex...

    Authors: Tomonobu Koizumi, Kengo Otsuki, Yuriko Tanaka and Shintaro Kanda
    Citation: BMC Endocrine Disorders 2022 22:105
  31. Obesity is a major public health concern in developed and even developing countries worldwide. Adiponectin is a protein secreted by adipose tissue that modulates many metabolic processes and plays a vital role...

    Authors: Masoumeh Nezhadali, Seyed Alireza Mesbah-Namin, Mehdi Hedayati, Mahdi Akbarzadeh, Leila Najd Hassan Bonab and Maryam S. Daneshpour
    Citation: BMC Endocrine Disorders 2022 22:104
  32. Chronic hyperglycemia in diabetes causes atherosclerosis and progresses to diabetic macroangiopathy, and can lead to coronary heart disease, myocardial infarction and cerebrovascular disease. Palmitoleic acid ...

    Authors: Yasuhiro Takenouchi, Yoshie Seki, Sachiko Shiba, Kazuo Ohtake, Koji Nobe and Keizo Kasono
    Citation: BMC Endocrine Disorders 2022 22:103
  33. Fine needle aspiration (FNA) cytology is the preferred method for assessing thyroid nodules for malignancy. Concern remains about the rate of false negative results. The primary aim of this study is to investi...

    Authors: Hafiz M. Zia-ul-Hussnain, Oratile Kgosidialwa, Carmel Kennedy, Mark Quinn, Emma Dolan, Paul Deignan, Mark Sherlock, Chris J. Thompson, Diarmuid Smith, James P. O’Neill, Arnold Hill, Mary Leader, Helen Barrett, Cliona Ryan, Frank Keeling, Martina M. Morrin…
    Citation: BMC Endocrine Disorders 2022 22:102
  34. The triglyceride glucose index combined with body mass index is a new index that reflects the degree of insulin resistance. In this cross-sectional study, we aimed to explore the predictive value of the trigly...

    Authors: Nong Li, Huiwen Tan, Aixia Xie, Cheng Li, Xuan Fu, Weiting Xang, Amina Kirim and Xuefang Huang
    Citation: BMC Endocrine Disorders 2022 22:101
  35. Several studies have assessed the relationship between type 2 diabetes (T2D) and tooth loss; however, results have been inconsistent. Therefore, the present systematic review and meta-analysis of observational...

    Authors: Amir Reza Ahmadinia, Donya Rahebi, Masoud Mohammadi, Mousa Ghelichi-Ghojogh, Alireza Jafari, Firooz Esmaielzadeh and Abdolhalim Rajabi
    Citation: BMC Endocrine Disorders 2022 22:100
  36. The co-occurrence of diabetes and osteoporosis is common in postmenopausal women. For the treatment of postmenopausal osteoporosis, current guidelines recommend initial treatment with bisphosphonates, but it i...

    Authors: Jinyoung Kim, Kyoung Min Kim, Soo Lim, Moo-Il Kang, Ki-Hyun Baek and Yong-Ki Min
    Citation: BMC Endocrine Disorders 2022 22:99
  37. Pseudohypoparathyroidism (PHP) encompasses a highly heterogenous group of disorders, characterized by parathyroid hormone (PTH) resistance caused by mutations in the GNAS gene or other upstream targets. Here, we ...

    Authors: Shaohan Huang, Yingzi He, Xihua Lin, Shuiya Sun and Fenping Zheng
    Citation: BMC Endocrine Disorders 2022 22:98
  38. Recently, side effects from Dopamine Receptor Agonist Drugs (DAs) in treating pituitary prolactinoma have raised widespread concern. This study explores the incidence and influencing factors of DAs-related sid...

    Authors: Xiaoan Ke, Linjie Wang, Meiping Chen, Shanshan Liu, Na Yu, Lian Duan, Fengying Gong and Huijuan Zhu
    Citation: BMC Endocrine Disorders 2022 22:97
  39. Endocrine disorders represent a large component of the so-called “chronic non-communicable diseases”, which are responsible for the lion share of morbidity and mortality in contemporary societies. As discussed in...

    Authors: Alexios-Fotios A. Mentis and George P. Chrousos
    Citation: BMC Endocrine Disorders 2022 22:96
  40. Recent epidemiological studies have indicated that NAFLD is pathologically associated with a sedentary lifestyle, unhealthy dietary habits and metabolic syndrome. An umbrella review of meta-analyses was perfor...

    Authors: Xiaojuan Peng, Juan Li, Hailiang Zhao, Junlong Lai, Junqin Lin and Shaohui Tang
    Citation: BMC Endocrine Disorders 2022 22:95
  41. Both obesity and subclinical hypothyroidism (SCH) have adverse effects on human body, but the relationship between these two conditions remains inconsistent. The presence of thyroid autoantibodies influences t...

    Authors: Yuerong Yan, Mingtong Xu, Muchao Wu, Xiaoyi Wang, Feng Li, Jin Zhang, Lili You, Xiaofang Pan, Weilian Feng, Jiayun Wu, Caixia Chen, Xiaohui Li and Li Yan
    Citation: BMC Endocrine Disorders 2022 22:94
  42. The efficacy of liraglutide to treat type 2 diabetic nephropathy (T2DN) remains controversial. Thus, we conducted this meta-analysis to systematically evaluate the clinical effect of liraglutide on T2DN patients.

    Authors: Niroj Mali, Feng Su, Jie Ge, Wen Xing Fan, Jing Zhang and Jingyuan Ma
    Citation: BMC Endocrine Disorders 2022 22:93
  43. This study aimed to compare the clinical features and prognoses of patients with and without diabetes mellitus (DM) who underwent endovascular repair for aortic aneurysm (AA).

    Authors: Mitsuyoshi Takahara, Osamu Iida, Junichi Tazaki, Ryusuke Nishikawa, Kiyonori Nanto, Yoshiro Chiba, Kazuhisa Sakamoto, Makoto Kinoshita, Naoki Takahashi, Satoshi Kamihira, Terutoshi Yamaoka, Hirooki Higami, Takeichiro Nakane, Takahiro Ohmine and Atsushi Guntani
    Citation: BMC Endocrine Disorders 2022 22:92

Annual Journal Metrics

  • 2022 Citation Impact
    2.7 - 2-year Impact Factor
    3.2 - 5-year Impact Factor
    1.159 - SNIP (Source Normalized Impact per Paper)
    0.733 - SJR (SCImago Journal Rank)

    2022 Speed
    23 days submission to first editorial decision for all manuscripts (Median)
    182 days submission to accept (Median)

    2022 Usage 
    5,496 Altmetric mentions 

Sign up for article alerts and news from this journal